ILF2 and exocrine pancreatic carcinoma: A first key finding was the discovery that the curcumin treatment of pancreatic carcinoma cells suppressed interleukin enhancer binding factor 2 (ILF2) overexpression, which regulated EMT-associated genes in this type of cancer (Bi et al., 2017).